Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Regulatory News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

25 Jun 2019 07:00

RNS Number : 2541D
Tiziana Life Sciences PLC
25 June 2019
 

For immediate release

 

 

Tiziana Life Sciences plc

(Incorporated in England and Wales with company number 09665181)

PDMR dealings

 

New York/London, 25 June 2019 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on 24 June 2019, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought ordinary shares of nominal value 3p each in the capital of the Company, as set out below, following prior consultation with the Takeover Panel in relation to Note 11 to Rule 9.1 of the City Code on Takeovers and Mergers.

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

 

1.

Details of PDMR / person closely associated

a)

Name

Gabriele Cerrone/Panetta Partners Limited

2.

Reason for the notification: On market acquisition

a)

Position / status

Executive Chairman

b)

Initial notification /amendment

Initial notification

3.

Details of the issuer

a)

Name

Tiziana Life Sciences plc

b)

LEI

213800CED47HI8PIOB36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of nominal value 3p each

b)

Identification code of the Financial Instrument

GB00BKWNZY55

c)

Nature of the transaction

On market acquisition of ordinary shares

d)

Price(s) and volume(s)

Price: £0.75; Volume: 7,500

e)

Aggregated information

- Aggregated volume

- Price

 

7,500

£5,625

 

 

 

 

f)

Date of the transaction

24 June 2019

g)

Place of the transaction

XLON

 

As a result of this transaction Mr Cerrone's interests in the underlying ordinary shares of the Company increases from 64,248,425 (47.080%) to 64,255,925 (47.086%). Mr Cerrone's interests in the ordinary shares of the Company are based on a holding of 63,680,404 ordinary shares held by Planwise Limited and voting rights in respect of 575,521 ordinary shares held by Panetta Partners Limited (as shares and via ADSs). Mr Cerrone is considered beneficially interested in the holdings of Panetta Partners Limited and Planwise Limited.

For more information go to http://www.tizianalifesciences.com

 

Contacts:

 

Tiziana Life Sciences plc

Gabriele Cerrone, Chairman and founder

 

 

 

+44 (0)20 7493 2853

Cairn Financial Advisers LLP (Nominated adviser)

Liam Murray / Jo Turner

+44 (0)20 7213 0883

Stockdale Securities (Broker)

Antonio Bossi / Andy Crossley

 

+44 (0)20 7601 6100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBLGDLDDDBGCS
Date   Source Headline
11th Oct 20071:34 pmRNSHolding(s) in Company
1st Oct 20077:01 amRNSProduct Launch
20th Sep 20077:00 amRNSInterim Results
19th Sep 20077:02 amRNSChange of Adviser
23rd Aug 20077:00 amRNSResearch Update
21st Aug 200711:59 amRNSHolding(s) in Company
10th Aug 200711:52 amRNSHolding(s) in Company
1st Aug 20077:01 amRNSWebsite Compliance
16th Jul 20077:01 amRNSRe Contract
29th Jun 20077:02 amRNSTotal Voting Rights
21st Jun 200712:18 pmRNSHolding(s) in Company
20th Jun 20071:29 pmRNSHolding(s) in Company
14th Jun 20071:34 pmRNSIssue of Equity
11th Jun 20077:01 amRNSResearch Update
15th May 20071:00 pmRNSAGM Statement
15th May 200712:00 pmRNSAGM Statement
24th Apr 20074:44 pmRNSNotice of AGM
19th Apr 200710:01 amRNSHolding(s) in Company
19th Apr 200710:00 amRNSHolding(s) in Company
19th Mar 20077:03 amRNSFinal Results
28th Feb 20076:17 pmRNSTotal Voting Rights
14th Feb 20074:37 pmRNSHolding(s) in Company
14th Feb 20074:34 pmRNSHolding(s) in Company
14th Feb 20074:33 pmRNSHolding(s) in Company
12th Feb 20074:34 pmRNSHolding(s) in Company
12th Feb 20074:34 pmRNSHolding(s) in Company
12th Feb 20074:30 pmRNSHolding(s) in Company
6th Feb 20077:01 amRNSIssue of Equity
5th Feb 20077:01 amRNSResearch Update
2nd Feb 20071:33 pmRNSHolding(s) in Company
15th Jan 20074:39 pmRNSHolding(s) in Company
20th Dec 200611:19 amRNSTotal Voting Rights
15th Dec 20064:39 pmRNSHolding(s) in Company
12th Dec 20066:33 pmRNSDirector/PDMR Shareholding
11th Dec 20061:14 pmRNS5th Annual City Presentation
7th Dec 200611:00 amRNSResearch Update
5th Dec 20066:18 pmRNSDirector/PDMR Shareholding
26th Sep 200611:59 amRNSEGM Statement
26th Sep 20068:00 amRNSInterim Results
1st Sep 20063:19 pmRNSNotice of EGM
25th Aug 20067:00 amRNSResearch Update
17th Aug 200610:35 amRNSChange of Adviser
21st Jul 20067:00 amRNSIssue of Equity
14th Jul 20065:38 pmRNSTrading Statement
13th Jul 20067:01 amRNSLicence Agreement
4th Jul 200610:19 amRNSResponse to press comment
13th Jun 200611:57 amRNSAGM Statement
22nd May 200611:11 amRNSResearch Update
19th May 20067:00 amRNSNotice of AGM
12th May 20067:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.